Cst12, known as cystatin 12, emerges as a key player in cellular processes with its predicted function as an inhibitor of cysteine-type endopeptidases. Positioned to act upstream of negative regulation of peptidase activity, this gene is anticipated to exert its influence within the extracellular region, particularly notable for its expression in the reproductive system. The orthologous relationship with human CST12P further underscores the evolutionary conservation of its functional significance. As a cysteine protease inhibitor, Cst12 plays a vital role in maintaining cellular homeostasis by modulating the activity of cysteine-type endopeptidases, key enzymes involved in various cellular processes.
The activation of Cst12 involves a sophisticated interplay of molecular mechanisms orchestrated by a variety of chemical activators. The gene can be directly activated through the inhibition of histone deacetylation and DNA methylation, leading to an open chromatin structure that facilitates enhanced transcription. Indirect activation pathways encompass the inhibition of critical signaling pathways such as TGF-β, MAPK/ERK, PI3K/AKT, NF-κB, STAT3, JAK/STAT, Wnt, PI3K/mTOR, and Notch. By blocking these pathways, negative regulation on Cst12 is alleviated, allowing for increased gene expression and subsequent upregulation. This intricate regulatory network highlights the versatility and adaptability of Cst12 in responding to diverse environmental cues, emphasizing its significance in maintaining cellular integrity and modulating key cellular processes. Exploring the comprehensive landscape of Cst12 and its activation mechanisms contributes not only to our understanding of its role in cellular function but also provides a foundation for potential implications in broader biological contexts.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, an HDAC Inhibitor, directly activates Cst12 by inhibiting histone deacetylation, fostering an open chromatin structure that enhances Cst12 expression and facilitates its upregulation. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide, a Wnt Pathway Inhibitor, indirectly stimulates Cst12 by blocking the Wnt signaling pathway, relieving negative regulation and promoting increased Cst12 expression and upregulation. | ||||||